Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

Product portfolio
Potentially strong market reviews
Competitive analytics
Prospect partners
Mergers and acquisitions project data
Latest trends across a particular industry area
Research and development strategies
The analysis of new customers
A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853

Sort by:

Myeloperoxidase (MPO or EC 1.11.2.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Myeloperoxidase (MPO or EC 1.11.2.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Myeloperoxidase (MPO or EC 1.11.2.2) Drugs in Develo...

May 2022 35 pages

Myeloproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Myeloproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myeloproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 167 pages

Myopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Myopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...

May 2022 46 pages

Myotonic Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Myotonic Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myotonic Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 74 pages

Myxoid Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Myxoid Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myxoid Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 43 pages

Na+-K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pump or EC 7.2.2.13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Na+-K+ Exchanging ATPase (Sodium Potassium ATPase or Sodium Potassium Pump or EC 7.2.2.13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMAR...

May 2022 41 pages

NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Polymerase or PARP or EC 2.4.2.30) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

NAD+ ADP Ribosyltransferase (Poly Adenosine Diphosphate Ribose Polymerase or PARP or EC 2.4.2.30) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 103 pages

NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1 or MT-ND1 or EC 7.1.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

NADH Ubiquinone Oxidoreductase Chain 1 (NADH Dehydrogenase Subunit 1 or MT-ND1 or EC 7.1.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUM...

May 2022 36 pages

NADPH Oxidase (NOX or EC 1.6.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

NADPH Oxidase (NOX or EC 1.6.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY NADPH Oxidase (NOX or EC 1.6.3.1) Drugs in Development...

May 2022 68 pages

Natural Killer Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Natural Killer Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Natural Killer Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 98 pages

Nausea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nausea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nausea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...

May 2022 45 pages

Necrotizing Enterocolitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Necrotizing Enterocolitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Necrotizing Enterocolitis Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 41 pages

Neisseria Gonorrhoeae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neisseria Gonorrhoeae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neisseria Gonorrhoeae Infections Drugs in Development by Stages, Target, MoA, R...

May 2022 65 pages

Neonatal Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neonatal Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neonatal Respiratory Distress Syndrome Drugs in Development by Stages, Ta...

May 2022 39 pages

Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 55 pages

Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Netherton Syndrome (Trichorrhexis Invaginata, Bamboo...

May 2022 42 pages

Neuroendocrine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neuroendocrine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroendocrine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 173 pages

Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 52 pages

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Dr...

May 2022 59 pages

Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 38 pages

Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 88 pages

Neuromuscular Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuromuscular Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuromuscular Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 74 pages

Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Neuronal Acetylcholine Receptor...

May 2022 35 pages

Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Neuronal Acetylcholine Receptor S...

May 2022 36 pages

Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 85 pages

Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Ty...

May 2022 35 pages

Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nicotinamide N Methyltransferase (N...

May 2022 38 pages

Nicotine Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nicotine Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nicotine Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 57 pages

Niemann Pick C1 Like Protein 1 (NPC1L1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Niemann Pick C1 Like Protein 1 (NPC1L1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Niemann Pick C1 Like Protein 1 (NPC1L1) Drugs in...

May 2022 41 pages

Niemann Pick C1 Protein (NPC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Niemann Pick C1 Protein (NPC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Niemann Pick C1 Protein (NPC1) Drugs in Development by The...

May 2022 35 pages

Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nitric Oxide Synthase (NO Syn...

May 2022 56 pages

Nodal Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nodal Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nodal Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target,...

May 2022 55 pages

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Non Muscle Invasive Bladder Cancer (NMIB...

May 2022 102 pages

Non-Proliferative Diabetic Retinopathy (NPDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Non-Proliferative Diabetic Retinopathy (NPDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Non-Proliferative Diabetic Retinopathy (NPDR) Drugs in Development...

May 2022 40 pages

Non-Small Cell Lung Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Non-Small Cell Lung Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Non-Small Cell Lung Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 112 pages

Nonerosive Reflux Disease (NERD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nonerosive Reflux Disease (NERD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nonerosive Reflux Disease (NERD) Drugs in Development by Stages, Target, MoA, R...

May 2022 36 pages

Nongerminomatous (Nonseminomatous) Germ Cell Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nongerminomatous (Nonseminomatous) Germ Cell Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nongerminomatous (Nonseminomatous) Germ Cell Tumors Drugs in...

May 2022 37 pages

Nonmelanomatous Skin Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nonmelanomatous Skin Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nonmelanomatous Skin Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 116 pages

Nonstructural Protein 1 (NS1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nonstructural Protein 1 (NS1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nonstructural Protein 1 (NS1) Drugs in Development by Thera...

May 2022 38 pages

Nonstructural Protein 4B (NS4B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nonstructural Protein 4B (NS4B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nonstructural Protein 4B (NS4B) Drugs in Development by T...

May 2022 35 pages

Nonstructural Protein 5A (NS5A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nonstructural Protein 5A (NS5A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nonstructural Protein 5A (NS5A) Drugs in Development by T...

May 2022 52 pages

Norovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Norovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Norovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 58 pages

NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY NS5B (Nonstructural Protein 5B...

May 2022 50 pages

Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nuclear...

May 2022 38 pages

Obstructive Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Obstructive Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Obstructive Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 55 pages

Ocular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ocular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ocular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 164 pages

Ocular Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ocular Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ocular Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 112 pages

Ocular Pain (Eye Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ocular Pain (Eye Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ocular Pain (Eye Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 55 pages

Onchocerciasis (River Blindness) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Onchocerciasis (River Blindness) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Onchocerciasis (River Blindness) Drugs in Development by Stages, Target, MoA, R...

May 2022 40 pages

Open-Angle Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Open-Angle Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Open-Angle Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 81 pages